Tech News
← Home  ·  All topics

Independence

5 GoKawiil briefs on this topic

AI's Growing Role Raises Concerns Over Scientific Independence

Recent discussions highlight how increasing reliance on artificial intelligence in research could subtly influence scientific objectivity. Experts warn that AI tools might inadvertently sway research outcomes or priorities. The issue underscores the need for careful oversight as AI becomes more integrated into scientific processes.

Essay argues true independence relies on interdependence and assistive tools

A disabled writer describes living mostly within one engineered room, relying on mobility aids, delivery services, remote appointments and family help to carry out daily work and life. She argues this setup should be seen as a functioning form of independence rather than dependence, challenging the common idea that independence means doing everything alone and unaided.

Fast Company's Impact Council maps path for US innovation over next 250 years

Fast Company's Impact Council published a reflection tied to the America 250 celebration, examining how the country's founding spirit of risk-taking has driven technological breakthroughs from aviation to computing. The piece argues that sustaining this innovative edge for another quarter millennium requires deliberate policy and industry choices rather than assuming continuity.

Independence, MO voters recall councilman over Nebius data center tax breaks

John Perkins was removed from the Independence City Council after 68.05% of voters backed his recall in a special election tied to his support for roughly $6 billion in tax incentives for a Nebius data center. He is the third official connected to the March council vote to lose his seat, following losses by a fellow councilman and a mayoral candidate. Only about 11.5% of Jackson County's registered voters cast ballots in the recall.

Revolution Medicines wins FDA approval for pancreatic cancer drug after rejecting buyout offers

Revolution Medicines received FDA approval this week for a pancreatic cancer pill, a milestone that comes after the company fielded acquisition interest from larger pharmaceutical firms but chose to remain independent. The decision allowed it to bring the drug through regulatory approval on its own rather than as part of a larger acquirer's pipeline.